Technical Analysis for VOR - Vor Biopharma Inc.

Grade Last Price % Change Price Change
D 0.79 3.87% 0.03
VOR closed up 3.87 percent on Wednesday, November 20, 2024, on 38 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish 3.87%
New Downtrend Bearish 3.87%
Wide Bands Range Expansion 3.87%
Down 3 Days in a Row Weakness 3.87%
Down 4 Days in a Row Weakness 3.87%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 19 hours ago
60 Minute Opening Range Breakout about 20 hours ago
Rose Above 50 DMA about 20 hours ago
Up 5% about 20 hours ago
Up 3% about 20 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acute Myeloid Leukemia Tyrosine Kinase Receptors Therapies For Cancer Proteins Haematopoiesis Lintuzumab

Is VOR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.1399
52 Week Low 0.63
Average Volume 553,258
200-Day Moving Average 1.32
50-Day Moving Average 0.79
20-Day Moving Average 0.83
10-Day Moving Average 0.89
Average True Range 0.08
RSI (14) 47.37
ADX 25.12
+DI 23.92
-DI 25.66
Chandelier Exit (Long, 3 ATRs) 0.83
Chandelier Exit (Short, 3 ATRs) 0.90
Upper Bollinger Bands 1.01
Lower Bollinger Band 0.65
Percent B (%b) 0.4
BandWidth 42.97
MACD Line 0.02
MACD Signal Line 0.03
MACD Histogram -0.0114
Fundamentals Value
Market Cap 53.89 Million
Num Shares 67.8 Million
EPS -1.89
Price-to-Earnings (P/E) Ratio -0.42
Price-to-Sales 0.00
Price-to-Book 0.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.88
Resistance 3 (R3) 0.88 0.84 0.87
Resistance 2 (R2) 0.84 0.82 0.85 0.86
Resistance 1 (R1) 0.82 0.81 0.83 0.82 0.86
Pivot Point 0.79 0.79 0.79 0.79 0.79
Support 1 (S1) 0.76 0.77 0.77 0.77 0.73
Support 2 (S2) 0.73 0.75 0.73 0.73
Support 3 (S3) 0.71 0.73 0.72
Support 4 (S4) 0.71